Effect of amino groups of mesoporous silica nanoparticles on CpG oligodexynucleotide delivery

Science and Technology of Advanced Materials

Volumn 16, Issue 4, 2015, Pages

  Xu, Yi ^a   Claiden, Peter ^a   Zhu, Yufang ^a   Morita, Hiromi ^b   Hanagata, Nobutaka ^b  

^a UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

^b NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

Author keywords

amination; CpG delivery; cytokine induction; mesoporous silica

Indexed keywords

BODY FLUIDS; MESOPOROUS MATERIALS; NANOPARTICLES; SILICA;

3-AMINOPROPYLTRIETHOXYSILANE; CPG DELIVERY; CYTOKINES; DELIVERY SYSTEMS; MESOPOROUS SILICA; MESOPOROUS SILICA NANOPARTICLES; SERUM STABILITY; TRIMETHOXYSILANE;

AMINATION;

EID: 84940501563     PISSN: 14686996     EISSN: 18785514     Source Type: Journal    
DOI: 10.1088/1468-6996/16/4/045006     Document Type: Article

References (44)

1. Knežević N Ž and Durand J-O 2015 Targeted treatment of cancer with nanotherapeutics based on mesoporous silica nanoparticles ChemPlusChem. 80 26-36
2. Krieg A M 2002 CpG motifs in bacterial DNA and their immune effects Annu. Rev. Immunol. 20 709-60
3. Hanagata N 2012 Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system Int. J. Nanomed. 7 2181-95
4. Krieg A M, Yi A-K, Matson S, Waldschmidt T J, Bishop G A, Teasdale R, Koretzky G A and Klinman D M 1995 CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 546-9
5. Klinman D M 2004 Immunotherapeutic uses of CpG oligodeoxynucleotides Nat. Rev. Immunol. 4 249-58
6. Krieg A M 2006 Therapeutic potential of Toll-like receptor 9 activation Nat. Rev. Drug Discovery 5 471-84
7. Murad Y M and Clay T M 2009 CpG oligodeoxynucleotides as TLR9 agonists: therapeutic applications in cancer Bio. Drugs 23 361-75
8. Fonseca D E and Kline J N 2009 Use of CpG oligonucleotides in treatment of asthma and allergic disease Adv. Drug Delivery Rev. 61 256-62
9. Klinman D M, Klaschik S, Sato T and Tross D 2009 CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases Adv. Drug Delivery Rev. 61 248-55
10. Vollmer J et al 2004 Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities Eur. J. Immunol. 34 251-62
11. Sands H, Gorey-Feret L J, Cocuzza A J, Hobbs F W, Chidester D and Trainor G L 1994 Biodistribution and metabolism of internally 3H-labeled oligonucleotides: I. Comparison of a phosphodiester and a phosphorothioate Mol. Pharmacol. 45 932-43
12. Heikenwalder M, Polymenidou M, Junt T, Sigurdson C, Wagner H, Akira S, Zinkernage R l and Aguzzi A 2004 Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration Nat. Med. 10 187-92
13. Brown D A, Kang S-H, Gryaznov S M, DeDionisio L, Heidenreich O, Sullivan S, Xu X and Nerenberg M I 1994 Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding J. Biol. Chem. 269 26801-5
14. Levin A A 1999 A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides Biochim. Biophys. Acta. 1489 69-84
15. Wei M, Chen N, Li J, Yin M, Liang L, He Y, Song H, Fan C and Huang Q 2012 Polyvalent immunostimulatory nanoagents with self-assembled CpG oligonucleotide-conjugated gold nanoparticles Angew. Chem. Int. Edn Engl. 51 1202-6
16. Tao Y, Li Z, Ju E, Ren J and Qu X 2013 One-step DNA-programmed growth of CpG conjugated silver nanoclusters: a potential platform for simultaneous enhanced immune response and cell imaging Chem. Commun. 49 6918-20
17. Chen S, Zhang H, Chinnathambi S and Hanagata N 2013 Synthesis of novel chitosan-silica/CpG oligodeoxynucleotide nanohybrids with enhanced delivery efficiency Mater. Sci. Eng. C 33 3382-8
18. Wang C, Gong M, Wu J, Zhuo R and Cheng S 2014 Dual-functionalized calcium carbonate based gene delivery system for efficient gene delivery RSC Adv. 4 38623-9
19. Li Z, Barnes J C, Bosoy A, Stoddart J F and Zink J I 2012 Mesoporous silica nanoparticles in biomedical applications Chem. Soc. Rev. 41 2590-605
20. Colilla M, González B and Vallet-Regí M 2013 Mesoporous silica nanoparticles for the design of smart delivery nanodevices Biomater. Sci. 1 114-34
21. Kresge C T, Leonowicz M E, Roth W J, Vartuli J C and Beck J S 1992 Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism Nature 359 710-2
22. Vallet-Regi M, Balas F and Arcos D 2007 Mesoporous materials for drug delivery Angew. Chem. Int. Edn Engl. 46 7548-58
23. Pasqua A J D, Sharma K K, Shi Y L, Toms B B, Ouellette W, Dabrowiak J C and Asefa T 2008 Cytotoxicity of mesoporous silica nanomaterials J. Inorg. Biochem. 102 1416-23
24. Chiang Y D, Lian H Y, Leo S Y, Wang S G, Yamauchi Y and Wu K C W 2011 Controlling particle size and structural properties of mesoporous silica nanoparticles using the Taguchi method J. Phys. Chem. C 115 13158-65
25. Suzuki N, Jiang X, Radhakrishnan L, NTakai K, Shimasaki K, Huang Y T, Miyamoto N and Yamauchi Y 2011 Hybridization of photoactive titania nanoparticles with mesoporous silica nanoparticles and investigation of their photocatalytic activity Bull. Chem. Soc. Japan 84 812-7
26. Lian H Y, Kao Z K, Liao Y C, Yamauchi Y and Wu K C W 2013 Self-assembled mesoporous silica nanoparticles in controlled patterns produced by soft-lithography and ink-jet printing J. Nanosci. Nanotechnol. 13 2804-8
27. Lin D, Cheng Q, Jiang Q, Huang Y, Yang Z, Han S, Zhao Y, Guo S, Liang Z and Dong A 2013 Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo Nanoscale 5 4291-301
28. Du X, Xiong L, Dai S, Kleitz F and Qiao S 2014 Intracellular microenvironment-responsive dendrimer-like mesoporous nanohybrids for traceable, effective, and safe gene delivery Adv. Funct. Mater. 24 7627-37
29. Hom C, Lu J and Tamanoi F 2009 Silica nanoparticles as a delivery system for nucleic acid-based reagents J. Mater. Chem. 35 6308-16
30. Hartono S B, Yu M, Gu W, Yang J, Strounina E, Wang X, Qiao S and Yu C C 2014 Synthesis of multi-functional large pore mesoporous silica nanoparticles as gene carriers Nanotechnology 25 055701
31. Kim T H, Kim M, Eltohamy M, Yun Y R, Jang J H and Kim H W 2013 Efficacy of mesoporous silica nanoparticles in delivering BMP-2 plasmid DNA for in vitro osteogenic stimulation of mesenchymal stem cells J. Biomed. Mater. Res. A 101 1651-60
32. Kar M, Tiwari N, Tiwari M, Lahiri M and Gupta S S 2013 Poly-L-arginine grafted silica mesoporous nanoparticles for enhanced cellular uptake and their application in DNA delivery and controlled drug release Part. Part. Syst. Charact. 30 166-79
33. Nishikawa M, Matono M, Rattanakiat S, Matsuoka N and Takakura Y 2008 Enhanced immunostimulatory activity of oligodeoxynucleotides by Y-shape formation Immunology 124 247-55
34. Rattanakiat S, Nishikawa M, Funabashi H, Luo D and Takakura Y 2009 The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity Biomaterials 30 5701-6
35. Chinnathambi S, Chen S, Ganesan S and Hanagata N 2012 Binding mode of CpG oligodeoxynucleotides to nanoparticles regulates bifurcated cytokine induction via toll-like receptor 9 Sci. Rep. 2 534
36. Tao C, Zhu Y, Li X and Hanagata N 2015 Binding of CpG oligodeoxynucleotides to mesoporous silica nanoparticles for enhancing delivery efficiency Micropor. Mesopor. Mater. 204 91-8
37. Jambhrunkar S, Qu Z, Popat A, Yang J, Noonan O, Acauan L, Nor Y A, Yu C and Karmakar S 2014 Effect of surface functionality of silica nanoparticles on cellular uptake and cytotoxicity Mol. Pharmacol. 10 3642-55
38. Zhang Q, Neoh K G, Xu L, Lu S, Kang E, Mahendran R and Chiong E 2014 Functionalized mesoporous silica nanoparticles with mucoadhesive and sustained drug release properties for potential bladder cancer therapy Langmuir 30 6151-61
39. Tees D F J, Woodward J T and Hammer D A 2001 Reliability theory for receptor-ligand bond dissociation J. Chem. Phys. 114 7483-96
40. Mutwiri G K, Nichani A K, Babiuk S and Babiuk L A 2004 Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides J. Control. Release 97 1-17
41. Lee I H, Kwon H K, An S, Kim D, Kim S, Yu M K, Lee J H, Lee T S, Im S H and Jon S 2012 Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo Angew. Chem. Int. Edn Engl. 51 8800-5
42. Chen N et al 2014 Self-assembly of poly-adenine-tailed CpG oligonucleotide-gold nanoparticle nanoconjugates with immunostimulatory activity Small 10 368-75
43. Prelaud A R, Fuchs S, Weber K, Winter G, Coester C and Mueller R S 2013 In vitro effects of CpG oligodeoxynucleotides delivered by gelatin nanoparticles on canine peripheral blood mononuclear cells of atopic and healthy dogs - a pilot study Vet. Dermatol 24 494-e117
44. Zhu Y, Shi J, Li Y, Shen W, Dong X and Ruan M 2005 Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface Micropor. Mesopor. Mater. 85 75-81